Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Lascoux

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
AIDS Care|January 29, 2011
Correlates of poor perceived health among individuals living with HIV and HBV chronic infections: a longitudinal assessmentFabienne Marcellin, Karine Lacombe, Lionel Fugon, et al.
Antiviral Therapy|September 6, 2008
Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patientsKarine Lacombe, Joël Gozlan, Anders Boyd, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 18, 2010
Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assaysJean-Marie Sire, Muriel Vray, Mourad Merzouk, et al.
Plos One|August 17, 2017
Detectable HIV-RNA in semen of HIV controllersMarie-Laure Chaix, Faroudy Boufassa, Candice Meyzer, et al.
AIDS (London, England)|January 28, 2006
Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIVKarine Lacombe, Véronique Massari, Pierre-Marie Girard, et al.
Journal of Virus Eradication|February 21, 2025
Virological and serological outcomes in people with HIV-HBV coinfection who had discontinued tenofovir-containing antiretroviral therapy: Results from a prospective cohort studyAmir M Mohareb, Patrick Miailhes, Julie Bottero, et al.
The Journal of Infectious Diseases|June 24, 2021
HIV-1 RNA Kinetics in Blood Plasma and in Seminal Plasma of Men Starting a Dolutegravir-Based Triple-Combination Regimen at the Time of Primary HIV-1 InfectionJade Ghosn, Lambert Assoumou, Caroline Lascoux-Combe, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2011
Switch from enfuvirtide to raltegravir lowers plasma concentrations of darunavir and tipranavir: a pharmacokinetic substudy of the EASIER-ANRS 138 trialLauriane Goldwirt, Joséphine Braun, Nathalie de Castro, et al.
JMIR Research Protocols|April 6, 2021
Subclinical and Clinical Outcomes in Patients Coinfected With HIV and Chronic Hepatitis B Virus From Clinical Outpatient Centers in France: Protocol for an Ambispective, Longitudinal Cohort StudyAnders Boyd, Lorenza N C Dezanet, Raisha Kassime, et al.
Open Forum Infectious Diseases|October 30, 2020
Association of Hepatitis B Core-Related Antigen and Antihepatitis B Core Antibody With Liver Fibrosis Evolution in Human Immunodeficiency Virus-Hepatitis B Virus Coinfected Patients During Treatment With TenofovirRomuald Cruchet, Lorenza N C Dezanet, Sarah Maylin, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
AIDS Care|January 29, 2011
Correlates of poor perceived health among individuals living with HIV and HBV chronic infections: a longitudinal assessmentFabienne Marcellin, Karine Lacombe, Lionel Fugon, et al.
Antiviral Therapy|September 6, 2008
Comparison of the antiviral activity of adefovir and tenofovir on hepatitis B virus in HIV-HBV-coinfected patientsKarine Lacombe, Joël Gozlan, Anders Boyd, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 18, 2010
Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assaysJean-Marie Sire, Muriel Vray, Mourad Merzouk, et al.
Plos One|August 17, 2017
Detectable HIV-RNA in semen of HIV controllersMarie-Laure Chaix, Faroudy Boufassa, Candice Meyzer, et al.
AIDS (London, England)|January 28, 2006
Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIVKarine Lacombe, Véronique Massari, Pierre-Marie Girard, et al.
Journal of Virus Eradication|February 21, 2025
Virological and serological outcomes in people with HIV-HBV coinfection who had discontinued tenofovir-containing antiretroviral therapy: Results from a prospective cohort studyAmir M Mohareb, Patrick Miailhes, Julie Bottero, et al.
The Journal of Infectious Diseases|June 24, 2021
HIV-1 RNA Kinetics in Blood Plasma and in Seminal Plasma of Men Starting a Dolutegravir-Based Triple-Combination Regimen at the Time of Primary HIV-1 InfectionJade Ghosn, Lambert Assoumou, Caroline Lascoux-Combe, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2011
Switch from enfuvirtide to raltegravir lowers plasma concentrations of darunavir and tipranavir: a pharmacokinetic substudy of the EASIER-ANRS 138 trialLauriane Goldwirt, Joséphine Braun, Nathalie de Castro, et al.
JMIR Research Protocols|April 6, 2021
Subclinical and Clinical Outcomes in Patients Coinfected With HIV and Chronic Hepatitis B Virus From Clinical Outpatient Centers in France: Protocol for an Ambispective, Longitudinal Cohort StudyAnders Boyd, Lorenza N C Dezanet, Raisha Kassime, et al.
Open Forum Infectious Diseases|October 30, 2020
Association of Hepatitis B Core-Related Antigen and Antihepatitis B Core Antibody With Liver Fibrosis Evolution in Human Immunodeficiency Virus-Hepatitis B Virus Coinfected Patients During Treatment With TenofovirRomuald Cruchet, Lorenza N C Dezanet, Sarah Maylin, et al.
Pageof 8